Table 1.
Preoperative characteristics of patients undergoing 18F-DCFPyL PET/CT before robot-assisted radical prostatectomy and extended pelvic lymph-node dissection
| Baseline characteristics | |||
|---|---|---|---|
| Median | IQR | ||
| Age (years) | 67 | 61–70 | |
| Prostate volume (mL) | 39 | 30–56 | |
| Initial PSA (ng/mL) | 10.9 | 7.2–20.8 | |
| Positive biopsy cores (% of total cores) | 50 | 36.6–73.9 | |
| MSKCC risk of lymph-node metastases (%) | 14.3 | 10.1–30.2 | |
| n | % | ||
| Biopsy ISUP category [3]a | 1 | 5 | 4.3 |
| 2 | 37 | 31.6 | |
| 3 | 26 | 22.2 | |
| 4 | 31 | 26.5 | |
| 5 | 18 | 15.4 | |
| Total | 117 | 100.0 | |
| Clinical T-stage | 1c | 44 | 37.6 |
| 2a/b | 54 | 46.2 | |
| 2c | 11 | 9.4 | |
| 3a | 7 | 6.0 | |
| Missing | 1 | 0.9 | |
| Total | 117 | 100.0 | |
| EAU risk category [3] | Intermediate | 43 | 36.8 |
| High | 74 | 63.3 | |
| Total | 117 | 100.0 | |
IQR, interquartile range; PSA, prostate-specific antigen; MSKCC, Memorial Sloan Kettering Cancer Centre; ISUP, International Society of Urological Pathology; EAU, European Association of Urology
aISUP definition
ISUP 1 = Gleason score 3 + 3 = 6
ISUP 2 = Gleason score 3 + 4 = 7
ISUP 3 = Gleason score 4 + 3 = 7
ISUP 4 = Gleason score 4 + 4 = 8/Gleason score 3 + 5 = 8/Gleason score 5 + 3 = 8
ISUP 5 = Gleason score 4 + 5 = 9/Gleason score 5 + 4 = 9/Gleason score 5 + 5 = 10